• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯尼达明对两种小鼠肿瘤辐射效应的增强作用。

Potentiation of radiation effects on two murine tumors by lonidamine.

作者信息

Kim J H, Alfieri A A, Kim S H, Young C W

出版信息

Cancer Res. 1986 Mar;46(3):1120-3.

PMID:3943089
Abstract

Lonidamine is a potent inhibitor of spermatogenesis and a hyperthermic sensitizer. The principal established locus of biochemical action of lonidamine is a selective inhibitory effect of the energy metabolism either in NAD-linked reactions in germ cell mitochondria, as well as the glycolytic metabolism of a variety of tumor cell lines by means of inhibition of mitochondrially bound hexokinase. We carried out in vivo tumor experiments to determine whether lonidamine when combined with radiation could potentiate the cytotoxic effects of radiation on two murine tumors. The combined effects of single acute lonidamine (100 mg/kg) and single dose X-irradiation were evaluated on the transplanted methylcholanthrene-induced fibrosarcoma in BALB/c mice and on the radiation-induced fibrosarcoma in C3H/He mice. The radiosensitizing effect by lonidamine was maximal when lonidamine was administered immediately prior to or after X-irradiation. The dose modifying factor of lonidamine is estimated to be 1.36 for methylcholanthrene-induced fibrosarcoma tumors and 1.25 for radiation-induced fibrosarcoma tumors. There was no disproportionately enhanced skin reaction following the combined treatments. The present results of the potentiating effects of radiation may be attributed, in part, to the findings of cell culture studies that lonidamine is a potent inhibitor of repair of potentially lethal damage.

摘要

氯尼达明是一种有效的精子发生抑制剂和热增敏剂。氯尼达明已确定的主要生化作用位点是对能量代谢的选择性抑制作用,这一作用既体现在生殖细胞线粒体中与NAD相关的反应中,也体现在通过抑制线粒体结合型己糖激酶对多种肿瘤细胞系的糖酵解代谢的抑制作用上。我们进行了体内肿瘤实验,以确定氯尼达明与辐射联合使用时是否能增强辐射对两种小鼠肿瘤的细胞毒性作用。评估了单次急性给予氯尼达明(100 mg/kg)和单次X射线照射对BALB/c小鼠移植的甲基胆蒽诱导的纤维肉瘤以及C3H/He小鼠辐射诱导的纤维肉瘤的联合效应。当在X射线照射之前或之后立即给予氯尼达明时,其放射增敏作用最大。氯尼达明对甲基胆蒽诱导的纤维肉瘤肿瘤的剂量修正因子估计为1.36,对辐射诱导的纤维肉瘤肿瘤为1.25。联合治疗后皮肤反应没有不成比例地增强。辐射增效作用的当前结果可能部分归因于细胞培养研究的结果,即氯尼达明是潜在致死性损伤修复的有效抑制剂。

相似文献

1
Potentiation of radiation effects on two murine tumors by lonidamine.氯尼达明对两种小鼠肿瘤辐射效应的增强作用。
Cancer Res. 1986 Mar;46(3):1120-3.
2
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.氯尼达明对艾氏腹水癌细胞能量代谢的影响。
Cancer Res. 1981 Nov;41(11 Pt 1):4661-6.
3
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.氯尼达明,一种小鼠肿瘤细胞有氧糖酵解的选择性抑制剂。
J Natl Cancer Inst. 1981 Mar;66(3):497-9.
4
Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.氯尼达明单独及与其他药物联合对小鼠RIF-1细胞和人HT1080细胞的体外细胞毒性。
Cancer Res. 1990 Dec 15;50(24):7867-70.
5
Potentiation of radiation effects on multicellular tumor spheroids (MTS) of HeLa cells by lonidamine.
Int J Radiat Oncol Biol Phys. 1989 May;16(5):1277-80. doi: 10.1016/0360-3016(89)90298-8.
6
Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization.氯尼达明诱导的、pH 依赖性的细胞氧利用抑制。
Radiat Res. 1988 Feb;113(2):356-61.
7
Enhancement of radiation response of prostatic carcinoma by lonidamine.氯尼达明增强前列腺癌的辐射反应。
Anticancer Res. 1996 Nov-Dec;16(6B):3665-71.
8
Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.三氧化二砷与分次照射在局部晚期小鼠肿瘤中的协同相互作用。
Cancer Res. 2002 Aug 1;62(15):4202-5.
9
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.使用CpG寡脱氧核苷酸靶向Toll样受体9可增强肿瘤对分割放疗的反应。
Clin Cancer Res. 2005 Jan 1;11(1):361-9.
10
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.氟达拉滨增强小鼠肿瘤辐射诱导的再生长延迟
Cancer Res. 1994 Jan 15;54(2):468-74.

引用本文的文献

1
Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.氯尼达明诱导前列腺癌异种移植瘤的选择性酸化和去能化:增强肿瘤对放射治疗的反应。
Cancers (Basel). 2024 Mar 31;16(7):1384. doi: 10.3390/cancers16071384.
2
Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate.酸性鞘磷脂酶-C 神经酰胺诱导的血管损伤决定结直肠癌细胞干命运。
Cell Physiol Biochem. 2022 Aug 31;56(4):436-448. doi: 10.33594/000000562.
3
Tumoral oxygenation and biodistribution of Lonidamine oxygen microbubbles following localized ultrasound-triggered delivery.
瘤内氧合及超声触发局部给药后洛尼达明氧微泡的生物分布。
Int J Pharm. 2022 Sep 25;625:122072. doi: 10.1016/j.ijpharm.2022.122072. Epub 2022 Aug 3.
4
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.氯尼达明联合化疗和物理治疗在癌症治疗中的潜力
Cancers (Basel). 2020 Nov 11;12(11):3332. doi: 10.3390/cancers12113332.
5
Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic Agent.通过短时间给予一种短效的抗血管生成药物增强吉西他滨治疗软组织肉瘤的疗效。
Cell Physiol Biochem. 2020 Jul 29;54(4):707-718. doi: 10.33594/000000250.
6
The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer and .新型小分子 SR18662 有效抑制结直肠癌生长。
Mol Cancer Ther. 2019 Nov;18(11):1973-1984. doi: 10.1158/1535-7163.MCT-18-1366. Epub 2019 Jul 29.
7
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.黑色素瘤模型代谢活性差异对洛尼达明联合多柔比星反应的影响。
Sci Rep. 2018 Oct 2;8(1):14654. doi: 10.1038/s41598-018-33019-4.
8
AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.中性鞘氨醇酶在促进结肠癌细胞生长功能中作为 AKT 的关键靶点。
Oncogene. 2018 Jul;37(28):3852-3863. doi: 10.1038/s41388-018-0236-x. Epub 2018 Apr 17.
9
Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide.氯尼达明对替莫唑胺全身治疗DB-1人黑色素瘤异种移植瘤的影响。
Anticancer Res. 2017 Jul;37(7):3413-3421. doi: 10.21873/anticanres.11708.
10
Targeting acid sphingomyelinase with anti-angiogenic chemotherapy.用抗血管生成化疗靶向酸性鞘磷脂酶
Cell Signal. 2017 Jan;29:52-61. doi: 10.1016/j.cellsig.2016.09.010. Epub 2016 Oct 1.